These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28984492)

  • 41. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.
    Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V
    Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
    Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
    Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
    Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis.
    Kepka L; Cieslak E; Bujko K; Fijuth J; Wierzchowski M
    Acta Oncol; 2005; 44(4):389-98. PubMed ID: 16120548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new model outperforming RPA and DS-GPA scores for individualized survival prediction of patients following whole brain irradiation for brain metastasis.
    Marchand-Crety C; Riverain J; Drouet Y; Felici F; Jeandidier CL; Thariat J; Servagi-Vernat S
    Cancer Radiother; 2021 Jul; 25(5):447-456. PubMed ID: 33678525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases.
    Lee HL; Chung TS; Ting LL; Tsai JT; Chen SW; Chiou JF; Leung HW; Liu HE
    Radiat Oncol; 2012 Oct; 7():181. PubMed ID: 23110940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Confirmatory Analysis of QUARTZ Study Results: Survival Prolongation After Whole-brain Radiotherapy.
    Nieder C; Dalhaug A; Pawinski A
    Anticancer Res; 2020 Feb; 40(2):977-981. PubMed ID: 32014942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gamma knife radiosurgery for treatment of cerebral metastases from non-small-cell lung cancer.
    Motta M; del Vecchio A; Attuati L; Picozzi P; Perna L; Franzin A; Bolognesi A; Cozzarini C; Calandrino R; Mortini P; di Muzio N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e463-8. PubMed ID: 21530098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
    Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Whole brain radiotherapy for poor prognosis patients with brain metastases: predictably poor results.
    Estabrook NC; Lutz ST; Johnson CS; Henderson MA
    J Support Oncol; 2013 Dec; 11(4):190-5. PubMed ID: 24645339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Recursive Partitioning Analysis and Graded Prognostic Assessment on Identifying Non-Small Cell Lung Cancer Patients with Brain Metastases Who May Benefit from Postradiation Systemic Therapy.
    Liu S; Chen P; Liu YW; Gu XN; Qiu XG; Li B
    Chin Med J (Engl); 2018 May; 131(10):1206-1213. PubMed ID: 29722340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution.
    Fleckenstein K; Hof H; Lohr F; Wenz F; Wannenmacher M
    Strahlenther Onkol; 2004 May; 180(5):268-73. PubMed ID: 15127156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
    Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
    Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of recursive partitioning analysis classification in patients with brain metastases from non-small cell lung cancer treated with short-course accelerated radiotherapy.
    Agarwal JP; Wadasadawala T; Munshi A; Chadda P; Apsani R; Upasani M; Laskar SG; Pramesh CS; Karimundackal G; Menon H; Prabhash K; Jambhekar N
    Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):837-43. PubMed ID: 20591632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.